Not financial advice — factual framing to help you form your own view.

Control Structure (foundation for both cases)

EOSE: ~31–32% stake (largest holder), board seat (Nathaniel Fick), preferred-stock board designation rights, milestone-setting authority over the credit agreement, discretionary $105M revolver, weekly CEO check-ins.

FPUSA: 4 of 7 board seats (majority), management authority via a Cerberus affiliate, $100M commitment, 3-year transfer restrictions, warrants at $5.481 (exercisable now).

Frontier Power UK: 4-of-8 board split with named hard vetoes over equity issuance, dividends, buybacks, and capitalising profits; a floating charge over all Frontier Power Limited's assets; consent-locks on key project agreements.

Bull Case

1. Real, accelerating operations — record Q2 2026 revenue of $68–$69M, roughly tripling shipments and driving backlog to $807M. Line 2 began commercial production June 16, 2026; full production targeted Q4 2026. Timothy Sykes

2. Sell-side conviction holds — Truist started coverage with a Buy rating and a $7 target, pointing to big manufacturing expansion, a strong pipeline, and what it sees as undervalued growth, reiterated July 23. Timothy SykesCNN

3. Defense diversification — a multi-million-dollar "Golden Dome for America" defense partnership using Z3 zinc-based storage, with room to scale. Timothy Sykes

4. Cerberus's control could stabilize the platform — with board majority at FPUSA, a veto seat in the UK, and the largest EOSE stake, Cerberus's own warrants and equity only pay off if all three vehicles execute — giving it real incentive to keep the platform solvent, not just extract value.

5. Missing DOE Tranche 2 isn't existential — the termination right (Section 2.02(c)) is scoped to Tranche 1 only; a missed Tranche 2 longstop has a 120-day cure window before any indirect default risk.

Bear Case

1. The RPO-vs-"backlog" gap is the single biggest red flag in the numbers
Eos publicly promotes a rising "commercial backlog" ($644.6M–$807M), but the audited, legally binding Remaining Performance Obligations (RPO) disclosed in Note 3 of its own 10-Q/10-K filings tell a very different story:

• Mid-2025: RPO ~$77M
• End of FY2025 (10-K): RPO fell to $45.8M, with ~83% expected to convert to revenue within 12 months
• Q1 2026 (10-Q, exact filed figure): RPO fell further to $30,997,000 (~$31.0M), ~82% converting within 12 months

That's roughly a 60% collapse in contractually binding near-term revenue in under a year, even as the promotional backlog figure kept climbing toward $807M. The gap exists because "backlog" includes non-binding or related-party items — notably the FPUSA capacity reservation, a deal EOSE effectively did with its own controlling JV partner. The RPO is the number that reflects actual signed, enforceable customer commitments; the backlog headline is the number management leads with. That divergence is exactly the kind of detail that doesn't show up in press releases but does show up in the audited notes.

2. Cerberus controls every layer without needing majority ownership
A board seat plus largest-holder status plus milestone authority at EOSE; an outright 4-of-7 board majority at FPUSA; explicit vetoes and a floating charge in the UK. Voting control or a hard veto in all three entities simultaneously.

3. The full-ratchet anti-dilution trigger has reportedly fired
Both the Hudson Bay direct offering and the rights offering priced at $5.481 — below the $5.59 Cerberus conversion threshold flagged in the prospectus supplement — which by the terms described would trigger Cerberus's full-ratchet anti-dilution protection, adjusting Cerberus's conversion terms further in its favor at common shareholders' expense.

4. FPUSA's real ownership split shifted sharply against Eos after the shortfall
The originally reported FPUSA split (49% Eos / 51% Cerberus, based on a fully-subscribed $150M target) doesn't hold once actual proceeds are used. Using only the $37.7M genuinely raised via the rights offering, Eos's calculated stake in FPUSA drops to roughly 15.9%, against Cerberus ~63% and Hudson Bay ~21% — meaning Eos's ownership of its own primary growth vehicle shrank dramatically the moment shareholders declined to fully subscribe.

5. Cerberus's dilution exposure is large and exercisable now
Series B Preferred (~116.3M shares, fully converted) + SPA Warrant (~43.3M shares, $0.01 strike) + CCM Warrant (~20M shares, $5.481 strike, no 2026 gate).

6. The discretionary revolver is a lever, not a safety net — the $105M facility is available solely at Cerberus's discretion, not guaranteed by milestones.

7. DOE Tranche 2/3 deadlines are close and partly gated on Cerberus sign-off
Tranche 2 (~$117.3M) longstop is September 15, 2026, gated partly on a Cerberus milestone certification; Line 2 is only ~50% through SAT. Tranche 3 (~$67.5M) follows December 15, 2026.

8. The rights offering already flopped — only 6.9M of 27.4M units sold (25.2% take-up), raising $37.7M against a $150M target. Timothy Sykes

9. Analyst targets already cut, price already down sharply — Stifel to $10 from $12, JPMorgan to $6 from $9, stock down ~38% from above $5 (7/6) to ~$3.14 (7/29). Timothy Sykes + 2

10. Margins remain deeply negative — EBIT margin ~-285%, profit margin >-500%, 68%–69% gross margin loss guided for Q2. StocksToTradeTimothy Sykes

11. Legal overhang — two securities litigation firms have opened investigations into potential wrongdoing. Timothy Sykes

Bottom line: the bull case rests substantially on the promotional backlog figure and the operational ramp narrative. The bear case rests on what the audited filings actually say underneath that headline — RPO collapsing ~60% in a year, a ratchet mechanism that appears to have already triggered, and Eos's real stake in its own flagship growth vehicle shrinking to ~16% the moment the market tested shareholder demand. Both sets of facts are real; the RPO/backlog gap is arguably the most important one for judging whether the "story" (backlog, defense deal, Truist's $7 target) is outrunning the substance (binding contracted revenue, actual FPUSA ownership).